|Dr. Kyle Kingsley||Founder, Chairman & CEO||N/A||N/A||N/A|
|Ms. Amber Shimpa||CFO & Director||N/A||N/A||N/A|
|Mr. Ari Hoffnung||COO & Director||N/A||N/A||N/A|
|Mr. Eric Greenbaum J.D.||Chief Science Officer||N/A||N/A||N/A|
|Mr. Sam Gibbons||VP of Investor Relations||N/A||N/A||N/A|
Vireo Health International Inc. operates in cannabis industry in the United States. It engages in the cultivation, production, and sale of medical cannabis products to company owned and third party dispensaries. The company sells and distributes a suite of products through dispensaries, home delivery, and wholesale channels. The company is headquartered in Minneapolis, Minnesota.
Vireo Health International Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.